Understanding genomic testing in NSCLC Genomic testing for non-small cell lung cancer (NSCLC) has evolved from a optional add-on to a cornerstone of personalized care. At the recent AONN+ conference, a focused session explored how oncology nurses, advanced practitioners, and navigators can effectively use biomarker testing to inform treatment decisions across NSCLC subtypes. The goal…